Next Generation News and Research

RSS

New analysis method to identify interacting proteins in a protein degrader-dependent manner

Protein degraders, which induce the protein degradation of target proteins, are expected to be the "next-generation drugs" because they can remove disease-related proteins from cells.

8 Mar 2022

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

A new study examined a unique case of extended viral shedding in an immunocompromised patient that produced a series of SARS-CoV-2 immune escape mutations over a seven-month period.

8 Mar 2022

Thermostable next-generation vaccine candidate against SARS-CoV-2 variants of concern studied in mice

Researchers developed a highly thermo-tolerant vaccine candidate that elicited high nAb titers in mice against several SARS-CoV-2 variants of concerns.

8 Mar 2022

Current and future perspectives of mRNA technology

New research reports on the current and future perspectives on messenger ribonucleic acid technology, the platform on which the first successful COVID-19 vaccine was based.

8 Mar 2022

International Women's Day 2022: Breaking the Bias

The IWD theme for 2022 is #BreaktheBias; coming together to forge women's equality.

8 Mar 2022

Current progress in SARS-CoV-2 vaccine candidates

In a new study, researchers illustrated the current progress and obstacles in COVID-19 vaccine development.

7 Mar 2022

Canopy Biosciences launches next-generation ChipCytometry™ instrument for spatial biology with sub-cellular resolution

Canopy Biosciences, a Bruker Company, today announced the commercial launch of the CellScape™ system, the next generation in ChipCytometry™ instrumentation, advancing the cutting-edge for quantitative in situ spatial phenotyping.

From Bruker Nano Surfaces and Metrology 7 Mar 2022

Government makes progress towards manifesto commitment of delivering 50,000 more nurses by 2024

The government is on track to meet its manifesto commitment to deliver 50,000 more nurses in the NHS by 2024, with over 27,000 more nurses now working across the NHS.

7 Mar 2022

Combating COVID cytokine storm with targeted nucleic acid therapies

Researchers examine current nucleic acid-based treatments against COVID-19 and their methods of action.

6 Mar 2022

Study may pave the way for better multiple sclerosis drugs

Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.

4 Mar 2022

COVID-19 and the life sciences; what have we learned and where are we going?

News-Medical attended the 2022 SLAS press briefing where Peter Simpson, Michael Girardi, and Simon Meffan-Main gave their thoughts on the life sciences sector post-COVID-19.

From Society for Laboratory Automation and Screening (SLAS) 4 Mar 2022

Government invests £260 million to support health research and life sciences manufacturing

Patients across the country are set to benefit from cutting-edge medical advances and treatments as the government invests £260 million today (Wednesday 2 March) to support research and development, as well as the manufacturing of new drugs, devices and diagnostics.

2 Mar 2022

New technology can assist bioprosthetic heart valve patients by avoiding additional replacement surgery

An international study led by a researcher from Tel Aviv University offers a novel technology that can assist many patients implanted with bioprosthetic heart valve by avoiding additional complicated replacement surgery.

1 Mar 2022

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced positive top-line results from the Phase 2 part of the Phase 2/3 study of once-daily oral RHB-107 (upamostat) in non-hospitalized symptomatic COVID-19 patients, predominantly conducted in the U.S. (60/61 patients) as well as South Africa.

1 Mar 2022

€10 million ‘precision medicine’ research project launched to provide new insights into ALS

An ambitious academic, clinical and industry research programme that will provide new insights into our understanding of Motor Neuron Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS), was launched today by Tánaiste and Irish Minister for Enterprise, Trade and Employment, Leo Varadkar T.D.

1 Mar 2022

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

Mercia Asset Management, Calculus Capital, Downing Ventures and BGF scale joint investment in latest fundraise.

From MIP Discovery 1 Mar 2022

New review highlights lack of women in leadership positions on cardiovascular clinical trials

Women remain underrepresented in leading cardiovascular clinical trials, which corresponds with underrepresentation and a lack of gender diversity among presenters at scientific meetings, according to a review published today in the Journal of the American College of Cardiology.

28 Feb 2022

Research shows intergenerational effects of preconception opioids in male offspring rats

New research from scientists at Cummings School of Veterinary Medicine at Tufts University suggests opioid use before pregnancy - even if not used during pregnancy itself - could result in a higher likelihood that a mother's male offspring will develop type 2 diabetes and metabolic syndrome, conditions that increase the risk of heart disease and stroke.

28 Feb 2022

Understanding the gut microbiome could help personalize immunotherapy for melanoma

The largest study to date has confirmed the link between the gut microbiome and the response to cancer immunotherapy therapy for melanoma.

28 Feb 2022

Researchers develop new precision medicine technology for cancer immunotherapy

In recent years, great advances have been made in the development of new successful immunotherapies to treat cancer. CAR T-cell therapy and antibody treatments are two types of targeted immunotherapies that have revolutionized areas of cancer care.

28 Feb 2022

Next Generation News and Research

New analysis method to identify interacting proteins in a protein degrader-dependent manner

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

Thermostable next-generation vaccine candidate against SARS-CoV-2 variants of concern studied in mice

Current and future perspectives of mRNA technology

International Women's Day 2022: Breaking the Bias

Current progress in SARS-CoV-2 vaccine candidates

Canopy Biosciences launches next-generation ChipCytometry™ instrument for spatial biology with sub-cellular resolution

Government makes progress towards manifesto commitment of delivering 50,000 more nurses by 2024

Combating COVID cytokine storm with targeted nucleic acid therapies

Study may pave the way for better multiple sclerosis drugs

COVID-19 and the life sciences; what have we learned and where are we going?

Government invests £260 million to support health research and life sciences manufacturing

New technology can assist bioprosthetic heart valve patients by avoiding additional replacement surgery

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

€10 million ‘precision medicine’ research project launched to provide new insights into ALS

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

New review highlights lack of women in leadership positions on cardiovascular clinical trials

Research shows intergenerational effects of preconception opioids in male offspring rats

Understanding the gut microbiome could help personalize immunotherapy for melanoma

Researchers develop new precision medicine technology for cancer immunotherapy

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News